Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2007
12/25/2007US7312030 Monitoring capability of genetically engineered arterivirus to propagate in cells; viricides; veterinary medicine; genetic vaccines
12/25/2007US7311922 comprising antigens and excipients, which increse serological sensitivity of individuals infected with tuberculosis; for use in diagnosis and prevention of tuberculosis infection
12/25/2007US7311921 Effective against FIVDix, FIVUK8, FIVBang, FIVAom1, FIVAom2, FIVPet, and FIVShi.
12/25/2007US7311918 Generation of rotavirus subunit proteins for use in vaccines and methods of providing protective immunity to vertebrates, including humans, against rotavirus infection or disease; providing cell-mediated immune response
12/25/2007US7311917 Membrane proteins; fusion proteins; vaccines; kits
12/25/2007US7311915 peptide mixture; induce immunology response; gag protein; vaccines
12/25/2007US7311912 immunoglobulin heavy chain peptides used for delivery of enzymes, antibodies, single chain antigen binding proteins, antigen combining sites, nucleic acids, carbohydrates and lipids to a basolateral factor of an epithelial surfaces; tissue-targeted therapy
12/21/2007WO2007147133A1 Stabilized tetracycline compositions
12/21/2007WO2007147117A2 Methods of reducing or eliminating salmonella in reptiles and/or their eggs
12/21/2007WO2007146039A2 Crystalline forms of n-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl] thio]-2-thiazolyl]-4-piperidinecarboxamide
12/21/2007WO2007145689A1 Use of alpha-toxin for treating and preventing staphylococcus infections
12/21/2007WO2007145191A1 Coated tablet
12/21/2007WO2007144444A1 Active packaging that inhibits food pathogens
12/21/2007WO2007143934A1 Pharmaceutical composition for the prophylaxis and treatment of hiv infection and its use
12/21/2007WO2007143880A1 Compounds for preventing and treating bacterial infection and its preparation and use
12/21/2007WO2007143858A1 Dph2 gene deletion mutant and uses thereof
12/21/2007WO2007143851A1 Fermented plant extracts, methods of production and uses
12/21/2007WO2007081288A9 Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant
12/21/2007WO2007081287A9 Immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant
12/21/2007WO2007064620A3 Compositions comprising a combination of ccr5 and cxcr4 antagonists
12/21/2007WO2007038860A8 Odcase inhibitors as anti-virals and antibiotics
12/21/2007WO2007033444A3 Antiviral therapy with carbohydrate binding agents
12/21/2007WO2003064613A3 Amidases, nucleic acids encoding them and methods for making and using them
12/21/2007CA2682755A1 Fermented plant extracts, methods of production and uses
12/21/2007CA2655565A1 Dph2 gene deletion mutant and uses thereof
12/21/2007CA2655133A1 Use of alpha-toxin for treating and preventing staphylococcus infections
12/21/2007CA2654317A1 Single-chain multivalent binding proteins with effector function
12/21/2007CA2654101A1 Active food pathogen inhibitor packaging
12/20/2007US20070293585 Gossypol co-crytals and the use thereof
12/20/2007US20070293564 Dimeric compounds and their use as anti-viral agents
12/20/2007US20070293560 Compounds and compositions
12/20/2007US20070293555 4-methoxy-benzoic acid 1-imidazol-1-yl methyl-2-(4-fluorophenoxy)-ethyl ester; N-[(1-imidazol-1-yl methyl)-2-phenoxy-ethyl]-4-iodo-benzamide; cancer, inflammation, septic shock, infertility, preterm labor, pain, or an ischemia
12/20/2007US20070293517 Derivatives Of Chemotherapeutic Agents With A Formaldehyde Releasing Moiety
12/20/2007US20070293496 Nitrogen containing heterocyclic compounds and medicines containing the same
12/20/2007US20070293493 Oxazolidinone antibiotics and derivatives thereof
12/20/2007US20070293482 Process for Preparing Benzodiazepines
12/20/2007US20070293478 such as 1-Cyclopropyl-N-(2,4-dichlorobenzyl)-6-fluoro-8-methoxy-7-[3-methyl-4-(2-{[(methylamino)carbonyl]amino}-2-oxoethyl)piperazin-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxamide, used for the treatment and/or prophylaxis of viral diseases or infections, particularly against cytomegaloviruses
12/20/2007US20070293472 Novel 14 and 15 Membered Ring Compounds
12/20/2007US20070293469 Compositions and methods for the treatment and prevention of disease
12/20/2007US20070293448 Synthetic gagpol genes and their uses
12/20/2007US20070293444 Novel Nucleoside Transport Inhibitors
12/20/2007US20070293424 Antitumoral and Antiviral Peptides
12/20/2007US20070293418 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders
12/20/2007US20070293417 Polyamides for treating human papilloma virus
12/20/2007US20070292933 Inhibitors of serine proteases, particular HCV NS3-NS4A protease
12/20/2007US20070292545 Anti-infective agents and methods of use
12/20/2007US20070292499 Processes for the Preparation of Solid Dosage Forms of Amorphous Valganciclovir Hydrochloride
12/20/2007US20070292494 Carbohydrate-Derivatized Liposomes for Targeting Cellular Carbohydrate Recognition Domains of Ctl/Ctld Lectins, and Intracellular Delivery of Therapeutically Active Compounds
12/20/2007US20070292477 Association of Antimicrobial Compounds with Surfaces and Polymers
12/20/2007US20070292461 Oleaginous pharmaceutical and cosmetic foam
12/20/2007US20070292452 Vaccine Compositions Which Are Obtained From Streptomyces
12/20/2007US20070292450 Immunogenic Compositions of Staphylococcus Epidermidis Polypeptide Antigens
12/20/2007US20070292449 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
12/20/2007US20070292447 Peptide Minotopes of Mycobacterial Mannosylated Lipoglycans and Uses Thereof
12/20/2007US20070292437 Chlamydia PMP Proteins, Gene Sequences and Uses Thereof
12/20/2007US20070292435 Polypeptide for use in the treatment of tumors, autoimmune, inflammatory and viral diseases; graft vs. host disease
12/20/2007US20070292425 Chlamydia PMP Proteins, Gene Sequences and Uses Thereof
12/20/2007US20070292422 Using CD70 specific immunoglobulins to prevent and treat cell proliferative disorders; immunosuppressant
12/20/2007US20070292413 Comprised of three lipid elements: phosphatidyl choline, fatty-acyl-cholesterol esters, and at least one apolipoprotein; brain disorders; kits; efficiently target and deliver substances
12/20/2007US20070292404 Antimicrobial polymer conjugates
12/20/2007US20070292390 Broadly Cross-Reactive Hiv-1 Neutralizing Human Monoclonal Antibodies
12/20/2007US20070292359 Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
12/20/2007US20070292355 Alcohol-free drug or cosmetics carrier mixture of water, hydrophobic solvent, surfactant and gelling agent; oil in water emulsions
12/19/2007EP1867721A1 Angiostatin fragments and aggregate angiostatin and methods of use
12/19/2007EP1867718A2 Therapeutically useful synthetic oligonucleotides
12/19/2007EP1867658A1 Lactalbumin production process
12/19/2007EP1867339A1 Anti-viral agent
12/19/2007EP1867336A2 Adminstration of an anti-endotoxin drug by intravenous infusion
12/19/2007EP1867332A1 Pharmaceutical composition and method using antifungal agent in combination
12/19/2007EP1867329A2 5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamides as therapeutic compounds
12/19/2007EP1866339A2 Gitr binding molecules and uses therefor
12/19/2007EP1866319A1 Phosphono-pent-2-en-1-yl nucleosides and analogs
12/19/2007EP1866312A1 Cyclic iminopeptide derivatives
12/19/2007EP1866306A1 Imidazopyridine derivatives useful as inos inhibitors
12/19/2007EP1866291A1 Antibacterial amide macrocycles vi
12/19/2007EP1866283A2 4-fluorophenyl-derivatives of 1-{[1,5 -bis (4-chlorophenyl) -2-methyl-1h-pyrrol-3-yl]methyl} -4- methylpiperazine, synthesis process and uses thereof
12/19/2007EP1865982A1 Hydrogel composition for modulation of topical inflammatory response
12/19/2007EP1865968A2 Topical formulations of borinic acid antibodies and their methods of use
12/19/2007EP1865967A2 Compounds, compositions and methods for the treatment of viral infections and other medical disorders
12/19/2007EP1865961A1 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment
12/19/2007EP1865960A2 Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application
12/19/2007EP1865950A1 Compounds useful as modulators of the proteasome activity
12/19/2007EP1865930A1 Multilayered dosing systems
12/19/2007EP1597376B1 Chicken rna polymerase i promoter and the use thereof
12/19/2007EP1556021B1 Pharmaceutical compositions comprising flavonoids and menthol
12/19/2007EP1411921B1 Pharmaceutical compositions containing terbinafine and use thereof
12/19/2007EP1406872B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes
12/19/2007EP1326873A4 Combinatorial libraries of monosaccharides
12/19/2007EP1326856B1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity
12/19/2007EP1131449B1 Method for identifying inhibitors of ipc synthase
12/19/2007EP1095061B1 Peptides based on the sequence of human lactoferrin and their use
12/19/2007EP1091757B1 Alpha emitting constructs and uses thereof
12/19/2007EP1090033B2 Particles of hcv envelope proteins: use for vaccination
12/19/2007EP1032556B1 Pharmaceutically active compounds and methods of use
12/19/2007EP0772689B1 Retroviral vectors having a reduced recombination rate
12/19/2007EP0519001B2 PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION
12/19/2007CN101090977A Tripeptide and tetrapeptide thioethers
12/19/2007CN101090966A Attenuated chimeric flavivirus bearing attenuated japanese encephalitis virus gene as backbone
12/19/2007CN101090727A Intraoral disintegration type solid preparation containing povidone iodine
12/19/2007CN101090716A Treatment of HCV disorders